3504 views | 8 years ago
We caught up with Anthony Philippakis, Chief Data Officer at The Broad Institute, and Susan Tousi, Senior Vice President of Product Development at Illumina, at the 2018 Bio-IT World Conference in Boston,...
9781 views | 8 years ago
It’s time to rethink NIPT. Introducing the VeriSeq NIPT solution, a powerful screening test from Illumina that can provide information on the health of a developing fetus using a simple maternal blood...
2527 views | 8 years ago
Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital discusses why he recommends noninvasive prenatal testing (NIPT). He notes that its accuracy, sensitivity, and specificity...
52098 views | 8 years ago
The VeriSeq™ NIPT solution from Illumina is a powerful screening test that provides the most comprehensive view of the fetal genome using a simple maternal blood draw. Cell-free DNA, released by placental...
6745 views | 8 years ago
The increased ease of next-generation sequencing (NGS) means more data to interpret than ever before. The process for variant annotation, curation, and interpretation can be extremely cumbersome. The...
2123 views | 8 years ago
Accelerate your research with the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Quickly identify, annotate, and classify disease-relevant...
5552 views | 8 years ago
Simplify data analysis on the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Learn how to analyze, store, and share your data using BaseSpace...
24099 views | 8 years ago
Introducing the iSeq 100, the latest advancement in the world of next-generation sequencing (NGS) from Illumina. The iSeq 100 instrument leverages Illumina technological advances in its smallest and...